Literature DB >> 14665512

High expression of p40(tax) and pro-inflammatory cytokines and chemokines in the lungs of human T-lymphotropic virus type 1-related bronchopulmonary disorders.

Yoriko Yamazato1, Akiko Miyazato, Kazuyoshi Kawakami, Satomi Yara, Hiroshi Kaneshima, Atsushi Saito.   

Abstract

STUDY
OBJECTIVE: Human T-lymphotropic virus type 1 (HTLV-1) is closely associated with the development of certain pulmonary diseases, such as bronchiolitis, although the pathologic mechanism remains unclear. To elucidate the pathogenesis of HTLV-1-associated bronchopulmonary disorders, we analyzed the relationship between expression of p40(tax), a regulatory component of HTLV-1 that stimulates various host genes, and synthesis of pro-inflammatory cytokines and chemokines by cells in BAL fluid (BALF) obtained from HTLV-1-infected patients.
DESIGN: Reverse transcription-polymerase chain reaction was used to compare the expression of p40(tax) and pro-inflammatory cytokines and chemokines messenger RNA (mRNA) in BALF of 10 HTLV-1 carriers and 7 healthy subjects. We also studied the correlation between these parameters and the proportion of lymphocytes in BALF.
RESULTS: The expression levels of pro-inflammatory cytokines (interferon [IFN]-gamma, interleukin-2) and chemokines (monocyte chemotactic protein-1, macrophage inflammatory protein [MIP]-1alpha, IFN-gamma-inducible protein-10 [IP-10]) were significantly higher in BALF of patients than of healthy subjects. The expression of IFN-gamma and MIP-1alpha mRNA correlated with that of p40(tax). IFN-gamma and IP-10 mRNA expression correlated with the proportion of lymphocytes in BALF. The percentage of lymphocytes in BALF increased with higher expression levels of p40(tax) mRNA, although the correlation was not significant.
CONCLUSION: Our results suggested that p40(tax) seems be involved in the development of HTLV-1-associated bronchopulmonary disorders at least in part through the local production of pro-inflammatory cytokines and chemokines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14665512     DOI: 10.1378/chest.124.6.2283

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells.

Authors:  Philip J Norris; Dale F Hirschkorn; Deborah A DeVita; Tzong-Hae Lee; Edward L Murphy
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

2.  HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells.

Authors:  Natsumi Araya; Tomoo Sato; Hitoshi Ando; Utano Tomaru; Mari Yoshida; Ariella Coler-Reilly; Naoko Yagishita; Junji Yamauchi; Atsuhiko Hasegawa; Mari Kannagi; Yasuhiro Hasegawa; Katsunori Takahashi; Yasuo Kunitomo; Yuetsu Tanaka; Toshihiro Nakajima; Kusuki Nishioka; Atae Utsunomiya; Steven Jacobson; Yoshihisa Yamano
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

3.  Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous australians: results of a case-control study.

Authors:  Lloyd Einsiedel; Olivier Cassar; Emma Goeman; Tim Spelman; Virginia Au; Saba Hatami; Sheela Joseph; Antoine Gessain
Journal:  Open Forum Infect Dis       Date:  2014-05-28       Impact factor: 3.835

4.  Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells.

Authors:  Yuetsu Tanaka; Mariko Mizuguchi; Yoshiaki Takahashi; Hideki Fujii; Reiko Tanaka; Takuya Fukushima; Takeaki Tomoyose; Aftab A Ansari; Masataka Nakamura
Journal:  Retrovirology       Date:  2015-07-01       Impact factor: 4.602

5.  Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA).

Authors:  Naoko Yokohori; Akitoshi Sato; Mizue Hasegawa; Hideki Katsura; Kenzo Hiroshima; Tamiko Takemura
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

6.  Human T-Lymphotropic Virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of Indigenous Australians.

Authors:  Lloyd Einsiedel; Hai Pham; Kim Wilson; Rebecca Walley; Jocelyn Turpin; Charles Bangham; Antoine Gessain; Richard J Woodman
Journal:  PLoS Negl Trop Dis       Date:  2018-03-12

Review 7.  Human T Lymphotropic Virus and Pulmonary Diseases.

Authors:  Apio R N Dias; Luiz F M Falcão; Aline S C Falcão; Valéria M F Normando; Juarez A S Quaresma
Journal:  Front Microbiol       Date:  2018-08-14       Impact factor: 5.640

Review 8.  Pulmonary Manifestations of Primary Sjögren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.

Authors:  Sarthak Gupta; Marcela A Ferrada; Sarfaraz A Hasni
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

9.  Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case-control study.

Authors:  Lloyd Einsiedel; Hai Pham; Virginia Au; Saba Hatami; Kim Wilson; Tim Spelman; Hubertus Jersmann
Journal:  ERJ Open Res       Date:  2019-12-02

Review 10.  Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection.

Authors:  Lloyd Einsiedel; Fabian Chiong; Hubertus Jersmann; Graham P Taylor
Journal:  Retrovirology       Date:  2021-01-06       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.